Biocytogen
Prem Nelesh Kothandaraman Gowri is a skilled professional in biomedical engineering and business development, currently serving as a Business Development Representative at Biocytogen since July 2023. Prior experience includes a role as a Research Assistant at Boston University, where Prem conducted significant research on human mesenchymal stem cells as potential treatments for osteoarthritis, and contributed to various projects at Biogen, Harvard Medical School, and the Indian Academy of Sciences, focusing on cell biology, cancer research, and dietary evolution. Prem holds a Master's degree in Biomedical Engineering from Boston University and a Bachelor of Technology in Bioengineering from Shanmugha Arts, Science, Technology and Research Academy.
Biocytogen
2 followers
Biocytogen is a preclinical stage biotech that provides a one-stop solution for antibody discovery from target to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for antibody drug discovery, Biocytogen offers animal model generation, antibody fully human-mouse (RenMab mouse), therapeutic antibody discovery and development, in vivo/in vitro preclinical studies, CMC/CDMO, and regulatory affairs support.